Cara Therapeutics, Inc.
USD5.32
-0.14 (-2.56%)
CEO
Christopher A. Posner
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.80
Prev. Close
$5.46
Day Low
$5.28
Day High
$5.52
52W Low
$5.28
52W High
$31.32
Market Cap
$0.01B
Volume
0.24M
| 163 |
| $4.76 |
| 6 Feb 2025 | Posner Christopher | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 372 | $4.72 |
| 6 Nov 2024 | Posner Christopher | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 3,668 | $0.29 |
| 2 Aug 2024 | Posner Christopher | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 4,149 | $0.35 |
| 6 Jun 2024 | VOGELBAUM MARTIN | director | A-Award | Acquired | 301,295 | $0.00 |
| 6 Jun 2024 | VOGELBAUM MARTIN | director | A-Award | Acquired | 390,000 | $0.66 |
| 6 Jun 2024 | Ives Jeffrey L. | director | A-Award | Acquired | 150,647 | $0.00 |
| 6 Jun 2024 | Ives Jeffrey L. | director | A-Award | Acquired | 195,000 | $0.66 |
| 6 Jun 2024 | Boudreau Helen M | director | A-Award | Acquired | 195,000 | $0.66 |